Esperite NV ESP with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the firstinman clinical trials in treatment of Crohn's disease.

AmsterdamÂThe NetherlandsÂ17th May 2018 Esperite's The Cell Factory has signed today the agreement with PHARM the Italian CRO company which is preparing for the firstinman clinical trials using CFMEV107 EVs. A drug for treatment of Crohn&a...